These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3806971)
21. [Comparison of long-term survival between bone marrow transplantation and maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission]. Suzuki N; Koike T; Furukawa T; Niwano H; Maruyama S; Narita M; Takizawa J; Sato N; Hashimoto S; Nikkuni K; Toba K; Kishi K; Takahashi M; Aizawa Y; Shibata A Rinsho Ketsueki; 1997 Feb; 38(2):95-9. PubMed ID: 9059062 [TBL] [Abstract][Full Text] [Related]
22. [Prediction of remission in adult acute leukemia--the application of LDH/LCBM Index in a remission predictive model]. Miyachi H; Takemura Y; Toyama K; Higashi T; Yamaguchi N Rinsho Ketsueki; 1984 Oct; 25(10):1626-9. PubMed ID: 6520938 [No Abstract] [Full Text] [Related]
23. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878 [TBL] [Abstract][Full Text] [Related]
24. Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience. Reiffers J; Stoppa AM; Attal M; Michallet M; Marit G; Blaise D; Huguet F; Corront B; Cony-Makhoul P; Montastruc M Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):17-9. PubMed ID: 8099731 [TBL] [Abstract][Full Text] [Related]
25. Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study. Gianfaldoni G; Mannelli F; Baccini M; Antonioli E; Leoni F; Bosi A Br J Haematol; 2006 Jul; 134(1):54-7. PubMed ID: 16803567 [TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia. Xiao Z; Xue H; Li R; Zhang L; Yu M; Hao Y Am J Hematol; 2008 Mar; 83(3):203-5. PubMed ID: 17874451 [TBL] [Abstract][Full Text] [Related]
28. [Importance of changes in potassium in the management of patients with acute non-lymphoblastic leukemia]. Marazuela M; Díaz-Mediavilla J; Martínez R; del Potro E; Alvarez A; Espinós D Med Clin (Barc); 1986 Dec; 87(20):843-6. PubMed ID: 3807453 [No Abstract] [Full Text] [Related]
29. [Prognostic factors and predictive models of the different causes of failure in te induction of remission in acute nonlymphoblastic leukemia]. Lorenzo JI; Sanz MA; Martín-Aragonés G; Rafecas FJ; Martínez JA; Sanz G; Gomis F Med Clin (Barc); 1988 Jan; 90(4):151-5. PubMed ID: 3352348 [No Abstract] [Full Text] [Related]
30. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272 [TBL] [Abstract][Full Text] [Related]
31. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929 [TBL] [Abstract][Full Text] [Related]
32. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650 [TBL] [Abstract][Full Text] [Related]
33. Mode of decrease of leukemic cells and leukocytes during neocarzinostatin treatment. Masaoka T; Hasegawa Y; Yoshitake J; Ueda T; Takubo T Cancer Treat Rep; 1977; 61(1):73-5. PubMed ID: 140763 [No Abstract] [Full Text] [Related]
34. Ultrastructural study of leukemic cells before and after chemotherapy in acute leukemia. Wang ST; Shang BW Chin Med J (Engl); 1988 Apr; 101(4):245-8. PubMed ID: 3138081 [No Abstract] [Full Text] [Related]
35. Clinical & prognostic significance of blast cell morphology & cytochemistry in acute non-myelogenous leukaemia. Gupta AD; Barbhaya SA; Anita PK; Shetty PA Indian J Med Res; 1983 Dec; 78():828-35. PubMed ID: 6674172 [No Abstract] [Full Text] [Related]
36. [Chemotherapy and FAB classification]. Takeuchi J Rinsho Ketsueki; 1992 May; 33(5):592-8. PubMed ID: 1630010 [No Abstract] [Full Text] [Related]